Acquisition Announced
Scancell Holdings acquisition of Neuphoria Therapeutics
Announced 23 Jul 2026 · NASDAQ: NEUP
Advisers
Neuphoria Therapeutics
Target
- Financial adviser
- Legal adviser
- Target
- Neuphoria Therapeutics
- Acquirer
- Scancell Holdings
- Target based in
- United States
- Buyer based in
- United Kingdom
- Sector
- Biotech
- Tags
- Biotech, Behavioral Health
In the league tables
Similar deals
- Eli Lilly and Company acquisition of AtaiBeckley Jul 2026 · US$2.8bn · Biotech
- Otsuka acquisition of Transcend Therapeutics Mar 2026 · US$700m · Biotech
- Eli Lilly and Company acquisition of AttaiBeckley 2026 · US$3.8bn · Biotech
- Fresenius acquisition of mAbxience Oct 2026 · US$1.9bn · Biotech
- Lisata Therapeutics acquisition of Marea Therapeutics Sep 2026 · Biotech
Sources
- 23 Jul 2026 Scancell to Acquire Neuphoria, Concurrent $89 Million Private Financing cooley.com
- 24 Jul 2026 Press release (EX-99.1, exhibit), THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS sec.gov
